NUVEMZI

Class [005]
Pharmaceutical preparations for the treatment of neurological developmental disorders and for the treatment of neurological disorders, namely, Angelman syndrome, Fragile X syndrome, Fragile X-associated Tremor/Ataxia syndrome, autism, Prader-Willi syndrome, Tourette syndrome, Dravet syndrome, Lennox- Gastaut syndrome, CDKL5 disorder, 1p36 deletion syndrome, tuberous sclerosis complex, epilepsy, seizures, tics, stuttering, infantile spasms, attention deficit hyperactivity disorder, Alzheimer's disease, Huntington's disease, and other diseases and disorders of the brain and degenerative nerve diseases and disorders.